Home > Income Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Consolidated Net Profit

    Back to Income Statement
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹18 Cr₹-186 Cr₹376 Cr₹835 Cr

What is the latest Consolidated Net Profit of PIRAMAL PHARMA ?

The latest Consolidated Net Profit ratio of PIRAMAL PHARMA is ₹18 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹18 Cr
Mar2023₹-186 Cr
Mar2022₹376 Cr
Mar2021₹835 Cr

How is Consolidated Net Profit of PIRAMAL PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹18 Cr
Positive
Mar2023 ₹-186 Cr
Negative
Mar2022 ₹376 Cr
-54.98
Mar2021 ₹835 Cr -

Compare Consolidated Net Profit of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹30,544.1 Cr -1.1% -6.1% 62.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,699.0 Cr 0.6% -4.6% 20.7% Stock Analytics
DIVIS LABORATORIES ₹162,584.0 Cr 9.8% 4.5% 64.7% Stock Analytics
CIPLA ₹116,022.0 Cr -2.9% -3.9% 1.1% Stock Analytics
DR REDDYS LABORATORIES ₹102,463.0 Cr 0.9% -10.4% 0.1% Stock Analytics
ZYDUS LIFESCIENCES ₹98,434.8 Cr 0.9% -0.3% 27.9% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-1.1%

-6.1%

62.9%

SENSEX

2%

0.1%

8.6%


You may also like the below Video Courses